Tarsus Pharmaceuticals (TARS) Tax Rate (2020 - 2026)

Tarsus Pharmaceuticals (TARS) recorded quarterly Tax Rate of 51.94% in Q1 2026, down 233617.03% quarter-over-quarter from 0.02% in Q3 2022.

Tarsus Pharmaceuticals (TARS) Tax Rate (2020 - 2026) Analysis & Trends

Tarsus Pharmaceuticals' Tax Rate history runs 4 years deep, the most recent figure standing at 51.94% for Q1 2026.

In Q1 2026, Tax Rate changed N/A year-over-year to 51.94%; the TTM figure through Mar 2026 stood at 5.39% (changed N/A YoY), while the FY2025 annual figure was 3.2%, changed N/A from the prior year.
Tax Rate was 51.94% for Q1 2026 at Tarsus Pharmaceuticals, down from 0.02% in the prior quarter.
In the past five years, Tax Rate ranged from a high of 0.02% in Q3 2022 to a low of 51.94% in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-57.14
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-6.79
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	5.61
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	17.68
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Tarsus Pharmaceuticals	2.71 Bn	2.61 Bn	152.66 Mn	-51.94

Download Data